Vitreoretinal Lymphoma

  • Mary E. Aronow
  • Ian Yeung
  • Chi-Chao Chan
Living reference work entry


Primary vitreoretinal lymphoma (PVRL) is a variant of primary central nervous system lymphoma (PCNSL), mostly a high-grade, extra-nodal, non-Hodgkin’s lymphoma. Diffuse large B-cell lymphoma (DLBCL) represents the predominant subtype, while rare cases of T-cell and natural killer (NK) cell origin can occur. The hallmark clinical features include vitreous cells and subretinal pigment epithelial (RPE) infiltrates of lymphoma. PVRL frequently masquerades as uveitis, therefore establishing the diagnosis can be challenging. Vitreous or subretinal biopsy remains the gold standard for diagnosis. The majority of patients with PVRL ultimately develop PCNSL which is an aggressive malignancy associated with poor overall survival.


Optical Coherence Tomography Retinal Pigment Epithelium Cerebral Spinal Fluid Primary Central Nervous System Lymphoma Cystoid Macular Edema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. Ahluwalia MS, Peereboom DM. Primary central nervous system lymphoma. Curr Treat Options Neurol. 2010;12:347–59.CrossRefPubMedGoogle Scholar
  2. Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma. Discov Med. 2013;15:93–100.PubMedPubMedCentralGoogle Scholar
  3. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120:671–3.CrossRefPubMedGoogle Scholar
  4. Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR, Batchelor TT, Pulido JS. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist. 2011;16(11):1589–99.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Farkas T, Harbour JW, Davila RM. Cytologic diagnosis of intraocular lymphoma in vitreous aspirates. Acta Cytol. 2004;48:487–91.CrossRefPubMedGoogle Scholar
  6. Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol. 2008;92:383–8.CrossRefPubMedGoogle Scholar
  7. Itty S, Pulido JS. Rituximab for intraocular lymphoma. Retina. 2009;29:129–32.CrossRefPubMedGoogle Scholar
  8. Margolis R, Brasil OF, Lowder CY, et al. Vitrectomy for the diagnosis and management of uveitis of unknown cause. Ophthalmology. 2007;114:1893–7.CrossRefPubMedGoogle Scholar
  9. Riemens A, Bromberg J, Touitou V, et al. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study. JAMA Ophthalmol. 2015;133:191–7.CrossRefPubMedGoogle Scholar
  10. Shen DF, Zhuang Z, LeHoang P, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology. 1998;105:1664–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer India (outside the USA) 2016

Authors and Affiliations

  1. 1.Ophthalmic Oncology/Retina DivisionWilmer Eye Institute, Johns HopkinsBaltimoreUSA
  2. 2.Laboratory of ImmunologyNational Eye Institute, National Institutes of HealthBethesdaUSA

Personalised recommendations